2006•PubMedRequires access

[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Receptor activator of NF-kappaB ligand (RANKL)].

Hisataka Yasuda

Abstract

Identification of RANKL (receptor activator of NF-kappaB ligand), RANK (receptor activator of NF-kappaB) and OPG (osteoprotegerin) revealed the mechanisms regulating osteoclast differentiation and function. RANKL-RANK signaling is essential for the physiological osteoclast development and plays a major role in the pathological bone destruction. RANKL is a transmembrane protein, but soluble form (sRANKL) is circulated in blood stream. Change of sRANKL concentration was observed in several bone diseases. This paper reviews the potential of sRANKL measurement as a marker of bone diseases.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: RANKL, Osteoprotegerin, Osteoclast, Activator (genetics), RANK Ligand, Chemistry, Receptor, Cell biology